Tyrosine Kinase Inhibitors - A Review on Pharmacology, Metabolism and Side Effects

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|5|470-481

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.5, 2009-06, pp. : 470-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2827-2835

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology

By  

Current Drug Metabolism, Vol. 18, Iss. 3, 2017-03 ,pp. : 186-198

Bentham Science Publishers

Access to resources Recommend Favorite

Selective tyrosine kinase inhibitors

By Wilkinson S.E.   Harris W.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 462-483

Bentham Science Publishers

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite